C82.67 Cutaneous follicle center lymphoma, spleen

Name of the Condition

• Cutaneous Follicle Center Lymphoma, Spleen

Summary

Cutaneous follicle center lymphoma is a type of non-Hodgkin lymphoma that originates in the skin, specifically affecting B-cells. When involving the spleen, it represents a rare manifestation of this indolent lymphoma, characterized by the slow growth of cancerous lymphocytes. This condition may present with both cutaneous lesions and splenic involvement, requiring careful evaluation to assess systemic spread.

Causes

The exact cause of cutaneous follicle center lymphoma is not fully understood, but it is associated with genetic mutations in B-cells. Environmental factors and immune system dysfunction may contribute to its development. Splenic involvement may occur as part of the disease's natural progression or as a secondary site of lymphoma spread.

Risk Factors

• Age: More common in individuals over 60.
• Family history: A history of lymphoma can increase risk.
• Immune system deficiencies.
• Certain infections, such as hepatitis C.

Symptoms

• Painless skin nodules or plaques.
• Red or purple lesions on the skin.
• Lesions that may be localized or widespread.
• Pruritus (itching) in some cases.
• Splenomegaly (enlarged spleen) may occur, potentially causing abdominal discomfort or early satiety.

Diagnosis

Diagnosis involves a physical examination, medical history review, skin biopsy to confirm the presence of lymphoma, and imaging studies (e.g., CT or MRI) to assess splenic involvement. A bone marrow biopsy may be performed to evaluate for systemic spread. Laboratory tests, including complete blood counts and lactate dehydrogenase (LDH) levels, help assess disease activity.

Treatment Options

• Watchful waiting: Monitoring the condition without immediate treatment if symptoms are mild and disease is stable.
• Topical therapies: Creams or ointments applied to the skin for localized lesions.
• Radiation therapy: Targeted treatment for cutaneous lesions or splenic involvement.
• Systemic therapies: Chemotherapy or immunotherapy may be considered for advanced or progressive disease.
• Splenectomy: Surgical removal of the spleen in select cases with significant splenic involvement.

Prognosis and Follow-Up

Cutaneous follicle center lymphoma is typically indolent, with a good long-term prognosis. However, splenic involvement may indicate a more advanced stage, requiring closer monitoring. Regular follow-up appointments, including physical exams and imaging, are essential to assess treatment response and detect recurrence.

Complications

• Progression to more aggressive lymphoma.
• Infection due to impaired immune function.
• Organ dysfunction from splenic enlargement.
• Psychological distress related to chronic skin lesions.

Lifestyle & Prevention

• Protect the skin from excessive sun exposure to reduce irritation.
• Maintain a balanced diet and regular exercise to support overall health.
• Avoid known triggers for skin irritation or infection.
• Stay up-to-date with vaccinations, as recommended by a healthcare provider.

When to Seek Professional Help

Seek medical attention if you notice new or worsening skin lesions, experience unexplained abdominal pain or fullness, or develop systemic symptoms such as fever, night sweats, or unexplained weight loss.

Tips for Medical Coders

When coding for cutaneous follicle center lymphoma involving the spleen (C82.67), ensure documentation specifies both the cutaneous and splenic involvement to support the code assignment. Verify that the diagnosis aligns with histopathological confirmation and clinical findings. Accurate coding requires clear documentation of the primary site (skin) and secondary site (spleen) to reflect the condition appropriately.